Program at a Glance
Conference Topics
- Simeon Marasigan Memorial Lecture
BEAT AD: Brain Health Evaluation and Tailor-made measures for Prevention of Alzheimer’s Disease
| Session 1: Updates on the Epidemiology of Dementia and the ASIAN COSMIC |
| New Data on Preclinical Dementia. Prognosis and Risk Factors |
| COSMIC: Cohort Studies of Memory in an International Consortium |
| Social determinants and cognitive impairment in older populations |
| MMAP: Marikina Memory and Aging Project |
| Neuroprotective Model for Healthy Longevity among Malaysian Older Adults |
| Session 2: Disease Modifying Therapies in Alzheimer’s Disease |
| Towards Precision Medicine for Alzheimer’s Disease : Progress in Diagnostics and Therapeutics |
| Proposed Regional Framework on ARIA detection and management |
| Transcriptomic and Proteomic Changes Upon Treatment with Lecanemab in Patients with Early Alzheimer’s Disease |
| Session 3: Innovative Approach to Cognitive Decline: Technology and Biomarkers |
| Digital health in the management of dementia from detection to intervention |
| Computerized Cognitive Assessment (CoCOA) with a new concept |
| Mismatch problem in cognitive decline subjective complaints to objective measurements |
| Spatial Navigation in Alzheimer’s Disease: plasma biomarker, neuroimaging and virtual reality |
| Session 4: Integrative Rehabilitation and Non-Pharmacological Intervention |
| Integrative Rehabiliation of MCI and Dementia |
| Neuromodulation for MCI and Dementia |
| The Integrated Rehabilitation Model |
| Caregiver Burden Associated with Getting Lost Incidents in People with Alzheimer’s Disease |
| From Mood Disorder to Neurocognitive Impairment: Exploring Neural Connectivity, Metabolic Inflammation, and Non-pharmacological Intervention of dementia |
| Session 5: The WorldWide Fingers – Dementia Risk Reduction via multidomain interventions: from trials to implementation |
| The WorldWide Fingers |
| Filipino Multicomponent Intervention to Maintain Cognitive Performance in High-Risk Population (FINOMAIN) |
| Implementation of multidomain intervention to reduce risk of dementia among Malaysian older adults (My-AGELESS) |
| South Korean study to prevent the progression of frailty and aging-related diseases using a digital multidomain intervention (SUPERAGING) |
| Cognitive resilience and prevention of dementia |
| Session 6: Blood Biomarkers in Alzheimer’s: Clinical Experience and Future Horizon |
| Blood Biomarker in the Clinics: SEA Experience |
| Diagnostic Accuracy of Plasma AB42, p-tau181, and MoCA score as Composite Index for AD in Resource-Limited Settings |
| Blood Biomarkers in Alzheimer’s Disease: Past Present and What’s Next |
| Blood biomarkers for the early diagnosis of AD: Collaboration of Australia, Korea and Taiwan |
| Session 7: Neuroimaging Biomarkers and Building a Multidimensional Framework for Risk Profiling |
| Brain mapping and Brain neurodegenerative diseases |
| Altered Functional Networks in Blood Biomarker–Defined Preclinical AD |
| Experiences from utility of Thai Guideline for Nuclear Medicine Investigations of Neurocognitive Disorders- PETS in dementia |
| A Clinically Feasible Framework to Estimate Tau Pathology in the Alzheimer’s Disease Spectrum |
| Multi-Dimensional Risk Profiling of Alzheimer’s Disease: Integrating Genetic, Environmental, and Neuroimaging Insights |
| Session 8: Multidisciplinary Perspectives on Dementia: From Risk Reduction to Novel Therapies |
| Dementia risk reduction for all: considerations for population based versus high risk group approaches |
| Ageing in Asia: Need for Reliable Quantification Tools |
| Delphi Consensus on Physical Exercise and Lifestyle interventions for the Management of Early Cognitive Decline and Neurocognitive Disorders – Asian Perspectives |
| Unraveling Behavioral and Psychological Symptoms of Dementia (BPSD): Longitudinal Trends and Evidence-Based Management for Enhancing Quality of Life |
| AR1001, a New AD Drug Beyond Amyloid and Tau (Global Phase 3) |
